Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 May;103(1):1196–1202. doi: 10.1111/j.1476-5381.1991.tb12323.x

An electrophysiological study of the actions of angiotensin II at the sympathetic neuroeffector junction in the guinea-pig vas deferens.

J Ziogas 1, T C Cunnane 1
PMCID: PMC1908096  PMID: 1878757

Abstract

1. The effects of angiotensin II on sympathetic neuroeffector transmission in the guinea-pig vas deferens have been investigated by the use of intracellular and focal extracellular recording techniques to measure indirectly, the release of adenosine 5'-triphosphate (ATP). 2. Angiotensin II (10-100 nM) did not alter the amplitude of the first excitatory junction potential (e.j.p.) in a train but increased the amplitude of subsequent e.j.ps. There was a corresponding increase in the probability of occurrence of extracellularly recorded evoked excitatory junction currents (e.j.cs). Spontaneous quantal transmitter release was unaffected by angiotensin II. 3. The enhancement of transmitter release produced by angiotensin II was prevented by the angiotensin receptor antagonist, saralasin. 4. The increase in transmitter release produced by angiotensin II was due to an increase in the probability of transmitter release from individual varicosities and not due to any detectable change in the configuration of the nerve terminal impulse or to the induction of repetitive firing. 5. There was no overall enhancement of e.j.ps or e.j.cs by angiotensin II in reserpinized tissues. Surprisingly, the predominant effect of angiotensin II in reserpinized vasa deferentia was to inhibit evoked transmitter release, an effect reversed by indomethacin (3 microM). 6. The results show that angiotensin II increases the release of sympathetic transmitter by activating prejunctional angiotensin II receptors. However, when the co-transmitter noradrenaline was depleted, angiotensin II now inhibited transmitter release indirectly, presumably by stimulating prostaglandin formation in the smooth muscle cells which then inhibited release transjunctionally.

Full text

PDF
1196

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allcorn R. J., Cunnane T. C., Kirkpatrick K. Actions of alpha, beta-methylene ATP and 6-hydroxydopamine on sympathetic neurotransmission in the vas deferens of the guinea-pig, rat and mouse: support for cotransmission. Br J Pharmacol. 1986 Dec;89(4):647–659. doi: 10.1111/j.1476-5381.1986.tb11169.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bell C. Mechanism of enhancement by angiotensin II of sympathetic adrenergic transmission in the guinea pig. Circ Res. 1972 Sep;31(3):348–355. doi: 10.1161/01.res.31.3.348. [DOI] [PubMed] [Google Scholar]
  3. Blakeley A. G., Cunnane T. C., Petersen S. A. An electropharmacological analyses of the effects of some drugs on neuromuscular transmission in the vas deferens of the guinea-pig. J Auton Pharmacol. 1981 Dec;1(5):367–375. doi: 10.1111/j.1474-8673.1981.tb00075.x. [DOI] [PubMed] [Google Scholar]
  4. Blakeley A. G., Cunnane T. C. The packeted release of transmitter from the sympathetic nerves of the guinea-pig vas deferens: an electrophysiological study. J Physiol. 1979 Nov;296:85–96. doi: 10.1113/jphysiol.1979.sp012992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brock J. A., Cunnane T. C. Electrical activity at the sympathetic neuroeffector junction in the guinea-pig vas deferens. J Physiol. 1988 May;399:607–632. doi: 10.1113/jphysiol.1988.sp017099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brock J. A., Cunnane T. C. Relationship between the nerve action potential and transmitter release from sympathetic postganglionic nerve terminals. Nature. 1987 Apr 9;326(6113):605–607. doi: 10.1038/326605a0. [DOI] [PubMed] [Google Scholar]
  7. Brock J. A., Cunnane T. C., Starke K., Wardell C. F. Alpha 2-adrenoceptor-mediated autoinhibition of sympathetic transmitter release in guinea-pig vas deferens studied by intracellular and focal extracellular recording of junction potentials and currents. Naunyn Schmiedebergs Arch Pharmacol. 1990 Jul;342(1):45–52. doi: 10.1007/BF00178971. [DOI] [PubMed] [Google Scholar]
  8. Burnstock G. The changing face of autonomic neurotransmission. Acta Physiol Scand. 1986 Jan;126(1):67–91. doi: 10.1111/j.1748-1716.1986.tb07790.x. [DOI] [PubMed] [Google Scholar]
  9. Cunnane T. C., Manchanda R. Electrophysiological analysis of the inactivation of sympathetic transmitter in the guinea-pig vas deferens. J Physiol. 1988 Oct;404:349–364. doi: 10.1113/jphysiol.1988.sp017293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cunnane T. C., Manchanda R. On the factors which determine the time-courses of junction potentials in the guinea-pig vas deferens. Neuroscience. 1990;37(2):507–516. doi: 10.1016/0306-4522(90)90418-4. [DOI] [PubMed] [Google Scholar]
  11. Cunnane T. C., Stjärne L. Secretion of transmitter from individual varicosities of guinea-pig and mouse vas deferens: all-or-none and extremely intermittent. Neuroscience. 1982;7(11):2565–2576. doi: 10.1016/0306-4522(82)90085-9. [DOI] [PubMed] [Google Scholar]
  12. Ellis J. L., Burnstock G. Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea-pig vas deferens. Br J Pharmacol. 1989 Aug;97(4):1157–1164. doi: 10.1111/j.1476-5381.1989.tb12574.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Ferry C. B. The innervation of the vas deferens of the guinea-pig. J Physiol. 1967 Sep;192(2):463–478. doi: 10.1113/jphysiol.1967.sp008309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hirst G. D., Neild T. O. Some properties of spontaneous excitatory junction potentials recorded from arterioles of guinea-pigs. J Physiol. 1980 Jun;303:43–60. doi: 10.1113/jphysiol.1980.sp013269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Jackson E. K., Campbell W. B. A possible antihypertensive mechanism of propranolol: antagonism of angiotensin II enhancement of sympathetic nerve transmission through prostaglandins. Hypertension. 1981 Jan-Feb;3(1):23–33. doi: 10.1161/01.hyp.3.1.23. [DOI] [PubMed] [Google Scholar]
  16. Lanier S. M., Malik K. U. Attenuation by prostaglandins of the facilitatory effect of angiotensin II at adrenergic prejunctional sites in the isolated Krebs-perfused rat heart. Circ Res. 1982 Nov;51(5):594–601. doi: 10.1161/01.res.51.5.594. [DOI] [PubMed] [Google Scholar]
  17. Lanier S. M., Malik K. U. Facilitation of adrenergic transmission in the canine heart by intracoronary infusion of angiotensin II: effect of prostaglandin synthesis inhibition. J Pharmacol Exp Ther. 1983 Dec;227(3):676–682. [PubMed] [Google Scholar]
  18. Saye J., Binder S. B., Trachte G. J., Peach M. J. Angiotensin peptides and prostaglandin E2 synthesis: modulation of neurogenic responses in the rabbit vas deferens. Endocrinology. 1986 Nov;119(5):1895–1903. doi: 10.1210/endo-119-5-1895. [DOI] [PubMed] [Google Scholar]
  19. Starke K. Regulation of noradrenaline release by presynaptic receptor systems. Rev Physiol Biochem Pharmacol. 1977;77:1–124. doi: 10.1007/BFb0050157. [DOI] [PubMed] [Google Scholar]
  20. Stjärne L., Msghina M., Stjärne E. "Upstream" regulation of the release probability in sympathetic nerve varicosities. Neuroscience. 1990;36(3):571–587. doi: 10.1016/0306-4522(90)90001-k. [DOI] [PubMed] [Google Scholar]
  21. Trachte G. J. Angiotensin effects on vas deferens adrenergic and purinergic neurotransmission. Eur J Pharmacol. 1988 Feb 9;146(2-3):261–269. doi: 10.1016/0014-2999(88)90301-9. [DOI] [PubMed] [Google Scholar]
  22. Trachte G. J., Binder S. B., Peach M. J. Indirect evidence for separate vesicular neuronal origins of norepinephrine and ATP in the rabbit vas deferens. Eur J Pharmacol. 1989 May 30;164(3):425–433. doi: 10.1016/0014-2999(89)90250-1. [DOI] [PubMed] [Google Scholar]
  23. Westfall T. C. Local regulation of adrenergic neurotransmission. Physiol Rev. 1977 Oct;57(4):659–728. doi: 10.1152/physrev.1977.57.4.659. [DOI] [PubMed] [Google Scholar]
  24. White T. D. Role of adenine compounds in autonomic neurotransmission. Pharmacol Ther. 1988;38(2):129–168. doi: 10.1016/0163-7258(88)90095-2. [DOI] [PubMed] [Google Scholar]
  25. Ziogas J., Story D. F., Rand M. J. Effects of locally generated angiotensin II on noradrenergic transmission in guinea-pig isolated atria. Eur J Pharmacol. 1984 Oct 30;106(1):11–18. doi: 10.1016/0014-2999(84)90672-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES